These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15123408)

  • 1. Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?
    Moyad MA; Carroll PR
    Urol Clin North Am; 2004 May; 31(2):289-300. PubMed ID: 15123408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?
    Moyad MA; Carroll PR
    Urol Clin North Am; 2004 May; 31(2):301-11. PubMed ID: 15123409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening.
    Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up.
    Frattaroli J; Weidner G; Dnistrian AM; Kemp C; Daubenmier JJ; Marlin RO; Crutchfield L; Yglecias L; Carroll PR; Ornish D
    Urology; 2008 Dec; 72(6):1319-23. PubMed ID: 18602144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive lifestyle changes may affect the progression of prostate cancer.
    Ornish D; Weidner G; Fair WR; Marlin R; Pettengill EB; Raisin CJ; Dunn-Emke S; Crutchfield L; Jacobs FN; Barnard RJ; Aronson WJ; McCormac P; McKnight DJ; Fein JD; Dnistrian AM; Weinstein J; Ngo TH; Mendell NR; Carroll PR
    J Urol; 2005 Sep; 174(3):1065-9; discussion 1069-70. PubMed ID: 16094059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Step-by-step lifestyle changes that can improve urologic health in men, part I: What do I tell my patients?
    Moyad MA
    Prim Care; 2006 Mar; 33(1):139-63, ix. PubMed ID: 16516684
    [No Abstract]   [Full Text] [Related]  

  • 8. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
    Van Patten CL; de Boer JG; Tomlinson Guns ES
    J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to a low-fat diet in men with prostate cancer.
    Link LB; Thompson SM; Bosland MC; Lumey LH
    Urology; 2004 Nov; 64(5):970-5. PubMed ID: 15533488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A message from preventive medicine and your physician. Prostate cancer.
    Prev Med; 2000 Aug; 31(2 Pt 1):101-2. PubMed ID: 10938208
    [No Abstract]   [Full Text] [Related]  

  • 11. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of coronary risk factors and quality of life in coronary artery disease patients with versus without diabetes mellitus.
    Pischke CR; Weidner G; Elliott-Eller M; Scherwitz L; Merritt-Worden TA; Marlin R; Lipsenthal L; Finkel R; Saunders D; McCormac P; Scheer JM; Collins RE; Guarneri EM; Ornish D
    Am J Cardiol; 2006 May; 97(9):1267-73. PubMed ID: 16635593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II.
    Blanchard CM; Courneya KS; Stein K;
    J Clin Oncol; 2008 May; 26(13):2198-204. PubMed ID: 18445845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The National Cancer Institute Multi-Screening Trial.
    Prorok P
    Can J Oncol; 1994 Nov; 4 Suppl 1():98-9; discussion 100-1. PubMed ID: 8853500
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotterdam randomized pilot studies of screening for prostate cancer--an overview after 10 years.
    Schröder FH; Roobol MJ; Damhuis RA; de Koning HJ; Blijenberg BG; Van der Kwast TH; Kirkels WJ; Bangma CH
    J Natl Cancer Inst; 2005 May; 97(9):696. PubMed ID: 15870441
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological approaches to reducing the risk of prostate cancer.
    Rittmaster RS; Fleshner NE; Thompson IM
    Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle therapy for prostate cancer: does it work?
    Harv Mens Health Watch; 2007 Jul; 11(12):1-3. PubMed ID: 17687794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.